Ignite Creation Date:
2024-05-05 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00156026
Status:
COMPLETED
Last Update Posted:
2009-01-29
First Post:
2005-09-08
Brief Title:
Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1
Sponsor:
Ontario Clinical Oncology Group OCOG
Organization:
Ontario Clinical Oncology Group OCOG
Study Overview
Official Title:
Randomized Trial of Immediate Treatment vs Colposcopic Follow-up for Biopsy-Proven CIN 1
Status:
COMPLETED
Status Verified Date:
2009-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study looks at immediate treatment of a cervix with CIN 1 versus regular six-month follow-up with colposcopy and treatment if CIN 1 progresses
Detailed Description:
In women who present with biopsy-proven CIN 1 to compare the management approach of regular colposcopic follow-up and only treating progressive disease using the LEEP with an approach of immediate treatment using LEEP The primary outcome is progression to more advanced disease ie CIN 2 CIN 3 or cancer
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None